Gfr estimating equations: Getting closer to the truth?

Andrew D Rule, Richard J. Glassock

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The application of serum creatinine and cystatin C in patients with CKD has been limited to using estimated glomerular filtration rate (eGFR). Criteria for choosing the best GFR estimating equation are 1) accuracy in estimating measured GFR, 2) optimal discrimination of clinical outcomes, and 3) associationwith CKDrisk factors and outcomes similar to that of measured GFR. Notably, these criteria are often not in agreement; and while the last criterion is themost important, it has been widely overlooked. The primary problemwith eGFR is that the non- GFR determinants of serum creatinine and cystatin C, aswell as their surrogates (age, sex, and race), associatewith CKD risk factors and outcomes. This leads to a distorted understanding of CKD, though eGFR based on serum creatinine appears to be less biased than eGFR based on cystatin C. Because of this problem, the use of eGFR should be limited to settings where knowing actual GFR is relevant and eGFR is more informative about GFR than serum creatinine or cystatin C alone. Such settings include staging CKD severity by GFR and dosing medications cleared by glomerular filtration. Alternatively, the diagnosis of CKD, the longitudinal progression of CKD, and prognostic models for CKD are settings where serum creatinine and cystatin C can be better applied and interpreted without eGFR.

Original languageEnglish (US)
Pages (from-to)1414-1420
Number of pages7
JournalClinical Journal of the American Society of Nephrology
Volume8
Issue number8
DOIs
StatePublished - Jul 2013

Fingerprint

Glomerular Filtration Rate
Cystatin C
Creatinine
Serum

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

Gfr estimating equations : Getting closer to the truth? / Rule, Andrew D; Glassock, Richard J.

In: Clinical Journal of the American Society of Nephrology, Vol. 8, No. 8, 07.2013, p. 1414-1420.

Research output: Contribution to journalArticle

@article{8cc2cc1a261d4c4abb70ab3745a2087a,
title = "Gfr estimating equations: Getting closer to the truth?",
abstract = "The application of serum creatinine and cystatin C in patients with CKD has been limited to using estimated glomerular filtration rate (eGFR). Criteria for choosing the best GFR estimating equation are 1) accuracy in estimating measured GFR, 2) optimal discrimination of clinical outcomes, and 3) associationwith CKDrisk factors and outcomes similar to that of measured GFR. Notably, these criteria are often not in agreement; and while the last criterion is themost important, it has been widely overlooked. The primary problemwith eGFR is that the non- GFR determinants of serum creatinine and cystatin C, aswell as their surrogates (age, sex, and race), associatewith CKD risk factors and outcomes. This leads to a distorted understanding of CKD, though eGFR based on serum creatinine appears to be less biased than eGFR based on cystatin C. Because of this problem, the use of eGFR should be limited to settings where knowing actual GFR is relevant and eGFR is more informative about GFR than serum creatinine or cystatin C alone. Such settings include staging CKD severity by GFR and dosing medications cleared by glomerular filtration. Alternatively, the diagnosis of CKD, the longitudinal progression of CKD, and prognostic models for CKD are settings where serum creatinine and cystatin C can be better applied and interpreted without eGFR.",
author = "Rule, {Andrew D} and Glassock, {Richard J.}",
year = "2013",
month = "7",
doi = "10.2215/CJN.01240213",
language = "English (US)",
volume = "8",
pages = "1414--1420",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "8",

}

TY - JOUR

T1 - Gfr estimating equations

T2 - Getting closer to the truth?

AU - Rule, Andrew D

AU - Glassock, Richard J.

PY - 2013/7

Y1 - 2013/7

N2 - The application of serum creatinine and cystatin C in patients with CKD has been limited to using estimated glomerular filtration rate (eGFR). Criteria for choosing the best GFR estimating equation are 1) accuracy in estimating measured GFR, 2) optimal discrimination of clinical outcomes, and 3) associationwith CKDrisk factors and outcomes similar to that of measured GFR. Notably, these criteria are often not in agreement; and while the last criterion is themost important, it has been widely overlooked. The primary problemwith eGFR is that the non- GFR determinants of serum creatinine and cystatin C, aswell as their surrogates (age, sex, and race), associatewith CKD risk factors and outcomes. This leads to a distorted understanding of CKD, though eGFR based on serum creatinine appears to be less biased than eGFR based on cystatin C. Because of this problem, the use of eGFR should be limited to settings where knowing actual GFR is relevant and eGFR is more informative about GFR than serum creatinine or cystatin C alone. Such settings include staging CKD severity by GFR and dosing medications cleared by glomerular filtration. Alternatively, the diagnosis of CKD, the longitudinal progression of CKD, and prognostic models for CKD are settings where serum creatinine and cystatin C can be better applied and interpreted without eGFR.

AB - The application of serum creatinine and cystatin C in patients with CKD has been limited to using estimated glomerular filtration rate (eGFR). Criteria for choosing the best GFR estimating equation are 1) accuracy in estimating measured GFR, 2) optimal discrimination of clinical outcomes, and 3) associationwith CKDrisk factors and outcomes similar to that of measured GFR. Notably, these criteria are often not in agreement; and while the last criterion is themost important, it has been widely overlooked. The primary problemwith eGFR is that the non- GFR determinants of serum creatinine and cystatin C, aswell as their surrogates (age, sex, and race), associatewith CKD risk factors and outcomes. This leads to a distorted understanding of CKD, though eGFR based on serum creatinine appears to be less biased than eGFR based on cystatin C. Because of this problem, the use of eGFR should be limited to settings where knowing actual GFR is relevant and eGFR is more informative about GFR than serum creatinine or cystatin C alone. Such settings include staging CKD severity by GFR and dosing medications cleared by glomerular filtration. Alternatively, the diagnosis of CKD, the longitudinal progression of CKD, and prognostic models for CKD are settings where serum creatinine and cystatin C can be better applied and interpreted without eGFR.

UR - http://www.scopus.com/inward/record.url?scp=84881240069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881240069&partnerID=8YFLogxK

U2 - 10.2215/CJN.01240213

DO - 10.2215/CJN.01240213

M3 - Article

C2 - 23704300

AN - SCOPUS:84881240069

VL - 8

SP - 1414

EP - 1420

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

SN - 1555-9041

IS - 8

ER -